Evidence map›Paper›PMID 24586747›Full record

ArticlePloS one2014

A multiplex two-color real-time PCR method for quality-controlled molecular diagnostic testing of FFPE samples.

Jiyoun Yeo, Erin L Crawford, Thomas M Blomquist, Lauren M Stanoszek, Rachel E Dannemiller, Jill Zyrek, Luis E De Las Casas, Sadik A Khuder, James C Willey

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Jiyoun YeoDivision of Pulmonary/Critical Care and Sleep Medicine, Department of Medicine, University of Toledo Health Sciences Campus, Toledo, Ohio, United States of America.
Erin L CrawfordDivision of Pulmonary/Critical Care and Sleep Medicine, Department of Medicine, University of Toledo Health Sciences Campus, Toledo, Ohio, United States of America.
Thomas M BlomquistDivision of Pulmonary/Critical Care and Sleep Medicine, Department of Medicine, University of Toledo Health Sciences Campus, Toledo, Ohio, United States of America.
Lauren M StanoszekDivision of Pulmonary/Critical Care and Sleep Medicine, Department of Medicine, University of Toledo Health Sciences Campus, Toledo, Ohio, United States of America.
Rachel E DannemillerDivision of Pulmonary/Critical Care and Sleep Medicine, Department of Medicine, University of Toledo Health Sciences Campus, Toledo, Ohio, United States of America.
Jill ZyrekDepartment of Pathology, University of Toledo Health Sciences Campus, Toledo, Ohio, United States of America.
Luis E De Las CasasDepartment of Pathology, University of Toledo Health Sciences Campus, Toledo, Ohio, United States of America.
Sadik A KhuderDivision of Pulmonary/Critical Care and Sleep Medicine, Department of Medicine, University of Toledo Health Sciences Campus, Toledo, Ohio, United States of America.
James C WilleyDivision of Pulmonary/Critical Care and Sleep Medicine, Department of Medicine, University of Toledo Health Sciences Campus, Toledo, Ohio, United States of America ; Department of Pathology, University of Toledo Health Sciences Campus, Toledo, Ohio, United States of America.
University of Toledo · US

Funding

Standardized NanoArray PCR for Gene Expression Profiling of Lung CancerR21CA132806 · NCI · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI GODFREY, TONY E, MORRISON, TOM B · 2008 to 2009
$474k
Implementation of innovative RNA sample quality control methodsR21CA138397 · NCI · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI WILLEY, JAMES C. · 2010 to 2011
$385k
NCI NIH HHS CA132806NCI NIH HHS CA138397NCI NIH HHS R21 CA132806NCI NIH HHS R21 CA138397
6 · The paper itself

Abstract

backgroundReverse transcription quantitative real-time PCR (RT-qPCR) tests support personalized cancer treatment through more clinically meaningful diagnosis. However, samples obtained through standard clinical pathology procedures are formalin-fixed, paraffin-embedded (FFPE) and yield small samples with low integrity RNA containing PCR interfering substances. RT-qPCR tests able to assess FFPE samples with quality control and inter-laboratory reproducibility are needed.

methodsWe developed an RT-qPCR method by which 1) each gene was measured relative to a known number of its respective competitive internal standard molecules to control for interfering substances, 2) two-color fluorometric hydrolysis probes enabled analysis on a real-time platform, 3) external standards controlled for variation in probe fluorescence intensity, and 4) pre-amplification maximized signal from FFPE RNA samples. Reagents were developed for four genes comprised by a previously reported lung cancer diagnostic test (LCDT) then subjected to analytical validation using synthetic native templates as test articles to assess linearity, signal-to-analyte response, lower detection threshold, imprecision and accuracy. Fitness of this method and these reagents for clinical testing was assessed in FFPE normal (N = 10) and malignant (N = 10) lung samples.

resultsReagents for each of four genes, MYC, E2F1, CDKN1A and ACTB comprised by the LCDT had acceptable linearity (R(2)>0.99), signal-to-analyte response (slope 1.0 ± 0.05), lower detection threshold (<10 molecules) and imprecision (CV <20%). Poisson analysis confirmed accuracy of internal standard concentrations. Internal standards controlled for experimentally introduced interference, prevented false-negatives and enabled pre-amplification to increase signal without altering measured values. In the fitness for purpose testing of this two-color fluorometric LCDT using surgical FFPE samples, the diagnostic accuracy was 93% which was similar to that previously reported for analysis of fresh samples.

conclusionsThis quality-controlled two-color fluorometric RT-qPCR approach will facilitate the development of reliable, robust RT-qPCR-based molecular diagnostic tests in FFPE clinical samples.

Indexed as

HumansMolecular Diagnostic TechniquesMultiplex Polymerase Chain ReactionParaffin EmbeddingReal-Time Polymerase Chain ReactionTissue Fixation

Identifiers

PMID24586747
PMCPMC3931751
OpenAlexW2042488535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.